Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Carpenter

Showing results (261-270 of 530) with videos related to

Pageof 53
Sort By:
Schizophrenia Bulletin|January 1, 1974
The diagnosis and understanding of schizophrenia. Part I. Use of signs and symptoms for the identification of schizophrenic patientsW T Carpenter, J S Strauss, J J Bartko
Schizophrenia Bulletin|February 24, 2006
Treatment of schizophrenia negative symptoms: future prospectsStephen M Erhart, Stephen R Marder, William T Carpenter
Chest|January 1, 1999
Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDSC T Carpenter, P V Price, B W Christman
Cancer|August 1, 1991
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndromeB E Harris, J T Carpenter, R B Diasio
Drugs|May 24, 2005
First-episode schizophrenia: a focus on pharmacological treatment and safety considerationsDeanna L Kelly, Robert R Conley, William T Carpenter
The Journal of Clinical Investigation|January 1, 1988
Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicityR B Diasio, T L Beavers, J T Carpenter
Organic Letters|June 20, 2008
Synthesis of fluorogenic polymers for visualizing cellular internalizationShane L Mangold, Rachael T Carpenter, Laura L Kiessling
Schizophrenia Bulletin|January 1, 1985
Treatment of negative symptomsW T Carpenter, D W Heinrichs, L D Alphs
The Journal of Nervous and Mental Disease|March 1, 1985
Early insight and the management of schizophrenic decompensationD W Heinrichs, B P Cohen, W T Carpenter
Comprehensive Psychiatry|May 1, 1978
How reliable is the psychiatric history?J S Strauss, W T Carpenter, A T Nasrallah
Pageof 53

Showing results (261-270 of 530) with videos related to

Sort By:
Pageof 53
Schizophrenia Bulletin|January 1, 1974
The diagnosis and understanding of schizophrenia. Part I. Use of signs and symptoms for the identification of schizophrenic patientsW T Carpenter, J S Strauss, J J Bartko
Schizophrenia Bulletin|February 24, 2006
Treatment of schizophrenia negative symptoms: future prospectsStephen M Erhart, Stephen R Marder, William T Carpenter
Chest|January 1, 1999
Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDSC T Carpenter, P V Price, B W Christman
Cancer|August 1, 1991
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndromeB E Harris, J T Carpenter, R B Diasio
Drugs|May 24, 2005
First-episode schizophrenia: a focus on pharmacological treatment and safety considerationsDeanna L Kelly, Robert R Conley, William T Carpenter
The Journal of Clinical Investigation|January 1, 1988
Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicityR B Diasio, T L Beavers, J T Carpenter
Organic Letters|June 20, 2008
Synthesis of fluorogenic polymers for visualizing cellular internalizationShane L Mangold, Rachael T Carpenter, Laura L Kiessling
Schizophrenia Bulletin|January 1, 1985
Treatment of negative symptomsW T Carpenter, D W Heinrichs, L D Alphs
The Journal of Nervous and Mental Disease|March 1, 1985
Early insight and the management of schizophrenic decompensationD W Heinrichs, B P Cohen, W T Carpenter
Comprehensive Psychiatry|May 1, 1978
How reliable is the psychiatric history?J S Strauss, W T Carpenter, A T Nasrallah
Pageof 53